North America Narcolepsy Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

July 2017 | 121 pages | ID: N42739546B2EN
GlobalInfoResearch

Abstracts

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.

Scope of the Report:

This report focuses on the Narcolepsy Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Jazz Pharmaceuticals
• Teva Pharmaceutical
• Novartis
• Mylan

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Antioxidants Type
• Stimulants Type
• Other

Market Segment by Applications, can be divided into

• Daytime Extreme Sleepiness
• Cataplexia
• Others

There are 15 Chapters to deeply display the North America Narcolepsy Drug market.

Chapter 1, to describe Narcolepsy Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Narcolepsy Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Narcolepsy Drug, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Narcolepsy Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Narcolepsy Drug Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Narcolepsy Drug Introduction
1.2 Market Analysis by Type
  1.2.1 Antioxidants Type
  1.2.2 Stimulants Type
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 Daytime Extreme Sleepiness
  1.3.2 Cataplexia
  1.3.3 Others
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Jazz Pharmaceuticals
  2.1.1 Profile
  2.1.2 Narcolepsy Drug Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Jazz Pharmaceuticals Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Jazz Pharmaceuticals News
2.2 Teva Pharmaceutical
  2.2.1 Profile
  2.2.2 Narcolepsy Drug Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Teva Pharmaceutical News
2.3 Novartis
  2.3.1 Profile
  2.3.2 Narcolepsy Drug Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Novartis Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Novartis News
2.4 Mylan
  2.4.1 Profile
  2.4.2 Narcolepsy Drug Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Mylan Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Mylan News

3 NORTH AMERICA NARCOLEPSY DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 North America Narcolepsy Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Narcolepsy Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Narcolepsy Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Narcolepsy Drug Manufacturer Market Share
  3.4.2 Top 5 Narcolepsy Drug Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA NARCOLEPSY DRUG MARKET ANALYSIS BY COUNTRIES

4.1 North America Narcolepsy Drug Sales Market Share by Countries
4.2 North America Narcolepsy Drug Sales by Countries (2012-2017)
4.3 North America Narcolepsy Drug Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION NARCOLEPSY DRUG BY TYPE

5.1 North America Narcolepsy Drug Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Narcolepsy Drug Sales and Market Share by Type (2012-2017)
  5.1.2 North America Narcolepsy Drug Revenue and Market Share by Type (2012-2017)
5.2 Antioxidants Type Sales Growth and Price
  5.2.1 North America Antioxidants Type Sales Growth (2012-2017)
  5.2.2 North America Antioxidants Type Price (2012-2017)
5.3 Stimulants Type Sales Growth and Price
  5.3.1 North America Stimulants Type Sales Growth (2012-2017)
  5.3.2 North America Stimulants Type Price (2012-2017)
5.4 Other Sales Growth and Price
  5.4.1 North America Other Sales Growth (2012-2017)
  5.4.2 North America Other Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION NARCOLEPSY DRUG BY APPLICATION

6.1 North America Narcolepsy Drug Sales Market Share by Application (2012-2017)
6.2 Daytime Extreme Sleepiness Sales Growth (2012-2017)
6.3 Cataplexia Sales Growth (2012-2017)
6.4 Others Sales Growth (2012-2017)

7 UNITED STATES NARCOLEPSY DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Narcolepsy Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Narcolepsy Drug Sales and Market Share by Type
7.3 United States Narcolepsy Drug Sales by Application (2012-2017)
7.4 United States Narcolepsy Drug Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Narcolepsy Drug Sales and Market Share by Manufacturer
  7.4.2 United States Narcolepsy Drug Revenue and Market Share by Manufacturer
7.5 United States Narcolepsy Drug Export and Import (2012-2017)

8 CANADA NARCOLEPSY DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Narcolepsy Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Narcolepsy Drug Sales and Market Share by Type
8.3 Canada Narcolepsy Drug Sales by Application (2012-2017)
8.4 Canada Narcolepsy Drug Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Narcolepsy Drug Sales and Market Share by Manufacturer
  8.4.2 Canada Narcolepsy Drug Revenue and Market Share by Manufacturer
8.5 Canada Narcolepsy Drug Export and Import (2012-2017)

9 MEXICO NARCOLEPSY DRUG SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Narcolepsy Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Narcolepsy Drug Sales and Market Share by Type
9.3 Mexico Narcolepsy Drug Sales by Application (2012-2017)
9.4 Mexico Narcolepsy Drug Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Narcolepsy Drug Sales and Market Share by Manufacturer
  9.4.2 Mexico Narcolepsy Drug Revenue and Market Share by Manufacturer
9.5 Mexico Narcolepsy Drug Export and Import (2012-2017)

10 NARCOLEPSY DRUG MARKET FORECAST (2017-2022)

10.1 North America Narcolepsy Drug Sales, Revenue and Growth Rate (2017-2022)
10.2 Narcolepsy Drug Market Forecast by Countries (2017-2022)
  10.2.1 United States Narcolepsy Drug Forecast (2017-2022)
  10.2.2 Canada Narcolepsy Drug Forecast (2017-2022)
  10.2.3 Mexico Narcolepsy Drug Forecast (2017-2022)
10.3 Narcolepsy Drug Market Forecast by Type (2017-2022)
10.4 Narcolepsy Drug Market Forecast by Application (2017-2022)

11 NARCOLEPSY DRUG MANUFACTURING COST ANALYSIS

11.1 Narcolepsy Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Narcolepsy Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Narcolepsy Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Narcolepsy Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Narcolepsy Drug Picture
Table Product Specifications of Narcolepsy Drug
Figure North America Sales Market Share of Narcolepsy Drug by Types in 2016
Table Types of Narcolepsy Drug
Figure Antioxidants Type Picture
Table Major Manufacturers of Antioxidants Type
Figure Stimulants Type Picture
Table Major Manufacturers of Stimulants Type
Figure Other Picture
Table Major Manufacturers of Other
Table North America Narcolepsy Drug Sales Market Share by Applications in 2016
Table Applications of Narcolepsy Drug
Figure Daytime Extreme Sleepiness Picture
Figure Cataplexia Picture
Figure Others Picture
Figure United States Narcolepsy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Narcolepsy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Narcolepsy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Jazz Pharmaceuticals Narcolepsy Drug Type and Applications
Table Jazz Pharmaceuticals Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Narcolepsy Drug Type and Applications
Table Teva Pharmaceutical Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Narcolepsy Drug Type and Applications
Table Novartis Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Narcolepsy Drug Type and Applications
Table Mylan Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Narcolepsy Drug Sales by Manufacturer (2016-2017)
Figure North America Narcolepsy Drug Sales Market Share by Manufacturer in 2016
Figure North America Narcolepsy Drug Sales Market Share by Manufacturer in 2017
Table North America Narcolepsy Drug Revenue by Manufacturer (2016-2017)
Figure North America Narcolepsy Drug Revenue Market Share by Manufacturer in 2016
Figure North America Narcolepsy Drug Revenue Market Share by Manufacturer in 2017
Table North America Narcolepsy Drug Price by Manufacturers (2016-2017)
Figure Top 3 Narcolepsy Drug Manufacturer Market Share in 2016
Figure Top 3 Narcolepsy Drug Manufacturer Market Share in 2017
Figure Top 5 Narcolepsy Drug Manufacturer Market Share in 2016
Figure Top 5 Narcolepsy Drug Manufacturer Market Share in 2017
Figure North America Narcolepsy Drug Sales and Growth (2012-2017)
Table North America Narcolepsy Drug Sales by Countries (2012-2017)
Table North America Narcolepsy Drug Sales Market Share by Countries (2012-2017)
Figure North America 2012 Narcolepsy Drug Sales Market Share by Countries
Figure North America 2016 Narcolepsy Drug Sales Market Share by Countries
Figure North America Narcolepsy Drug Revenue and Growth (2012-2017)
Table North America Narcolepsy Drug Revenue by Countries (2012-2017)
Table North America Narcolepsy Drug Revenue Market Share by Countries (2012-2017)
Table North America 2012 Narcolepsy Drug Revenue Market Share by Countries
Table North America 2016 Narcolepsy Drug Revenue Market Share by Countries
Table North America Narcolepsy Drug Sales by Type (2012-2017)
Table North America Narcolepsy Drug Sales Share by Type (2012-2017)
Table North America Narcolepsy Drug Revenue by Type (2012-2017)
Table North America Narcolepsy Drug Revenue Share by Type (2012-2017)
Figure North America Antioxidants Type Sales Growth (2012-2017)
Figure North America Antioxidants Type Price (2012-2017)
Figure North America Stimulants Type Sales Growth (2012-2017)
Figure North America Stimulants Type Price (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure North America Other Price (2012-2017)
Table North America Narcolepsy Drug Sales by Application (2012-2017)
Table North America Narcolepsy Drug Sales Share by Application (2012-2017)
Figure North America Daytime Extreme Sleepiness Sales Growth (2012-2017)
Figure North America Cataplexia Sales Growth (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure United States Narcolepsy Drug Revenue and Growth (2012-2017)
Figure United States Narcolepsy Drug Sales and Growth (2012-2017)
Table United States Narcolepsy Drug Sales by Type (2012-2017)
Table United States Narcolepsy Drug Sales Market Share by Type (2012-2017)
Table United States Narcolepsy Drug Sales by Application (2012-2017)
Table United States Narcolepsy Drug Sales Market Share by Application (2012-2017)
Table United States Narcolepsy Drug Sales by Manufacturer (2016-2017)
Figure United States Narcolepsy Drug Sales Market Share by Manufacturer in 2016
Figure United States Narcolepsy Drug Sales Market Share by Manufacturer in 2017
Table United States Narcolepsy Drug Revenue by Manufacturer (2016-2017)
Figure United States Narcolepsy Drug Revenue Market Share by Manufacturer in 2016
Figure United States Narcolepsy Drug Revenue Market Share by Manufacturer in 2017
Table United States Narcolepsy Drug Export and Import (2012-2017)
Figure Canada Narcolepsy Drug Revenue and Growth (2012-2017)
Figure Canada Narcolepsy Drug Sales and Growth (2012-2017)
Table Canada Narcolepsy Drug Sales by Type (2012-2017)
Table Canada Narcolepsy Drug Sales Market Share by Type (2012-2017)
Table Canada Narcolepsy Drug Sales by Application (2012-2017)
Table Canada Narcolepsy Drug Sales Market Share by Application (2012-2017)
Table Canada Narcolepsy Drug Sales by Manufacturer (2016-2017)
Figure Canada Narcolepsy Drug Sales Market Share by Manufacturer in 2016
Figure Canada Narcolepsy Drug Sales Market Share by Manufacturer in 2017
Table Canada Narcolepsy Drug Revenue by Manufacturer (2016-2017)
Figure Canada Narcolepsy Drug Revenue Market Share by Manufacturer in 2016
Figure Canada Narcolepsy Drug Revenue Market Share by Manufacturer in 2017
Table Canada Narcolepsy Drug Export and Import (2012-2017)
Figure Mexico Narcolepsy Drug Revenue and Growth (2012-2017)
Figure Mexico Narcolepsy Drug Sales and Growth (2012-2017)
Table Mexico Narcolepsy Drug Sales by Type (2012-2017)
Table Mexico Narcolepsy Drug Sales Market Share by Type (2012-2017)
Table Mexico Narcolepsy Drug Sales by Application (2012-2017)
Table Mexico Narcolepsy Drug Sales Market Share by Application (2012-2017)
Table Mexico Narcolepsy Drug Sales by Manufacturer (2016-2017)
Figure Mexico Narcolepsy Drug Sales Market Share by Manufacturer in 2016
Figure Mexico Narcolepsy Drug Sales Market Share by Manufacturer in 2017
Table Mexico Narcolepsy Drug Revenue by Manufacturer (2016-2017)
Figure Mexico Narcolepsy Drug Revenue Market Share by Manufacturer in 2016
Figure Mexico Narcolepsy Drug Revenue Market Share by Manufacturer in 2017
Table Mexico Narcolepsy Drug Export and Import (2012-2017)
Figure North America Narcolepsy Drug Sales, Revenue and Growth Rate (2017-2022)
Table North America Narcolepsy Drug Sales Forecast by Countries (2017-2022)
Table North America Narcolepsy Drug Market Share Forecast by Countries (2017-2022)
Figure United States Narcolepsy Drug Sales Forecast (2017-2022)
Figure Canada Narcolepsy Drug Sales Forecast (2017-2022)
Figure Mexico Narcolepsy Drug Sales Forecast (2017-2022)
Table North America Narcolepsy Drug Sales Forecast by Type (2017-2022)
Table North America Narcolepsy Drug Market Share Forecast by Type (2017-2022)
Table North America Narcolepsy Drug Sales Forecast by Application (2017-2022)
Table North America Narcolepsy Drug Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Narcolepsy Drug
Figure Manufacturing Process Analysis of Narcolepsy Drug
Figure Narcolepsy Drug Industrial Chain Analysis
Table Raw Materials Sources of Narcolepsy Drug Major Manufacturers in 2016
Table Major Buyers of Narcolepsy Drug
Table Distributors/Traders/ Dealers List